Aevi Genomic Medicine Inc. (GNMX) Rose 6.84% or 0.08 To Price $1.25 On Wednesday


Aevi Genomic Medicine Inc. (GNMX) rose 6.84% or 0.08 to $1.25. It is nearly 68421 shares traded, which is 68.41% compare to the average total volume 100021. The market cap of GNMX is $74.18 million. The year to date change is 1.19%. The 52 week price range is from $0.83 to $2.65. Price of GNMX have changed -7.87% during last week. It have changed -5.65% over last month, 14.71% over last 3 months, -38.42% over last 6 months and -8.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.16. It is -7.20% below current price. The 200-day Moving Averages for GNMX is 1.48. It is 18.40% above current price. The 52-week High is 2.65. It is 112.00% from the current price. The 52-week Low is 0.83. It is -33.60% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 0.32 on 2018-09-14. Short % to float is 0.23%. There are some statistics of GNMX. It is has market cap $74.18 million. The share outstanding is 59.34 million. The average volume is 100021. The percent of top 15 Institution holding is 20.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -194.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -150.22%.


Tags:

Share this post